These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 16908599

  • 21. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C, Zazzeroni F, Papa S, Bubici C, Franzoso G.
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [Abstract] [Full Text] [Related]

  • 22. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
    Emi M, Maeyama K.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1259-67. PubMed ID: 15013841
    [Abstract] [Full Text] [Related]

  • 23. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal BB.
    Oncogene; 2007 Feb 22; 26(8):1201-12. PubMed ID: 16924232
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
    Sors A, Jean-Louis F, Bégué E, Parmentier L, Dubertret L, Dreano M, Courtois G, Bachelez H, Michel L.
    Clin Cancer Res; 2008 Feb 01; 14(3):901-11. PubMed ID: 18245554
    [Abstract] [Full Text] [Related]

  • 25. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J, Slivova V, Sliva D.
    Int J Oncol; 2006 Sep 01; 29(3):695-703. PubMed ID: 16865287
    [Abstract] [Full Text] [Related]

  • 26. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
    Hui AM, Zhang W, Chen W, Xi D, Purow B, Friedman GC, Fine HA.
    Cancer Res; 2004 Dec 15; 64(24):9115-23. PubMed ID: 15604281
    [Abstract] [Full Text] [Related]

  • 27. Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis.
    Kim YK, Lee EK, Kang JK, Kim JA, You JS, Park JH, Seo DW, Hwang JW, Kim SN, Lee HY, Lee HW, Han JW.
    Cell Death Differ; 2006 Dec 15; 13(12):2033-41. PubMed ID: 16628233
    [Abstract] [Full Text] [Related]

  • 28. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
    Braeuer SJ, Büneker C, Mohr A, Zwacka RM.
    Mol Cancer Res; 2006 Oct 15; 4(10):715-28. PubMed ID: 17050666
    [Abstract] [Full Text] [Related]

  • 29. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
    Lampiasi N, Azzolina A, D'Alessandro N, Umezawa K, McCubrey JA, Montalto G, Cervello M.
    Mol Pharmacol; 2009 Aug 15; 76(2):290-300. PubMed ID: 19461054
    [Abstract] [Full Text] [Related]

  • 30. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
    Manna SK, Gangadharan C.
    Mol Immunol; 2009 Apr 15; 46(7):1340-50. PubMed ID: 19128834
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G, Tabanca N, Husnu Can Baser K, Kirimer N, Pasco DS, Khan IA, Khan SI.
    Cancer Chemother Pharmacol; 2009 Mar 15; 63(4):673-80. PubMed ID: 18597088
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells.
    Rahman KW, Sarkar FH.
    Cancer Res; 2005 Jan 01; 65(1):364-71. PubMed ID: 15665315
    [Abstract] [Full Text] [Related]

  • 33. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
    Buchholz TA, Garg AK, Chakravarti N, Aggarwal BB, Esteva FJ, Kuerer HM, Singletary SE, Hortobagyi GN, Pusztai L, Cristofanilli M, Sahin AA.
    Clin Cancer Res; 2005 Dec 01; 11(23):8398-402. PubMed ID: 16322301
    [Abstract] [Full Text] [Related]

  • 34. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M, Tsuji N, Kobayashi D, Kuribayashi K, Watanabe N.
    Int J Oncol; 2009 May 01; 34(5):1363-72. PubMed ID: 19360348
    [Abstract] [Full Text] [Related]

  • 35. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.
    Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108
    [Abstract] [Full Text] [Related]

  • 36. Novel caffeic acid ester derivative induces apoptosis by expressing FasL and downregulating NF-KappaB: Potentiation of cell death mediated by chemotherapeutic agents.
    Bose JS, Gangan V, Jain SK, Manna SK.
    J Cell Physiol; 2009 Mar 01; 218(3):653-62. PubMed ID: 19034929
    [Abstract] [Full Text] [Related]

  • 37. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
    Schmid JA, Birbach A.
    Cytokine Growth Factor Rev; 2008 Apr 01; 19(2):157-65. PubMed ID: 18308615
    [Abstract] [Full Text] [Related]

  • 38. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M, Kodela R, Nath N, Barsegian A, Boring D, Kashfi K.
    Biochem Pharmacol; 2012 Mar 15; 83(6):723-32. PubMed ID: 22209867
    [Abstract] [Full Text] [Related]

  • 39. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
    Marín YE, Wall BA, Wang S, Namkoong J, Martino JJ, Suh J, Lee HJ, Rabson AB, Yang CS, Chen S, Ryu JH.
    Melanoma Res; 2007 Oct 15; 17(5):274-83. PubMed ID: 17885582
    [Abstract] [Full Text] [Related]

  • 40. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment.
    Schön M, Wienrich BG, Kneitz S, Sennefelder H, Amschler K, Vöhringer V, Weber O, Stiewe T, Ziegelbauer K, Schön MP.
    J Natl Cancer Inst; 2008 Jun 18; 100(12):862-75. PubMed ID: 18544741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.